title: Treatment of angioblastoma with recombinant interferon-alpha 2.
abstract: Interferon-alpha 2 has been used successfully to treat angiomatous lesions such as Kaposi sarcoma and life-threatening hemangiomas, possibly by its antiangiogenetic activity. We report the successful use of this agent in a child with an angioblastoma of the right leg.
authors.affiliation: Department of Dermatology, Seoul National University College of Medicine, Korea.
authors.forename: K C
authors.initials: KC
authors.lastname: Park
authors.forename: P S
authors.initials: PS
authors.lastname: Ahn
authors.forename: Y S
authors.initials: YS
authors.lastname: Lee
authors.forename: K H
authors.initials: KH
authors.lastname: Kim
authors.forename: K H
authors.initials: KH
authors.lastname: Cho
mesh_terms: D005260:Female; D005500:Follow-Up Studies; D018325:Hemangioblastoma / Q000628:therapy*; D006801:Humans; D007223:Infant; D015552:Injections, Intralesional; D007279:Injections, Subcutaneous; D007370:Interferon Type I / Q000008:administration & dosage / Q000627:therapeutic use*; D007866:Leg; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000628:therapy*
chemical_list: D007370:Interferon Type I; D011994:Recombinant Proteins